Published in Clin Immunol Immunopathol on October 01, 1995
A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med (1992) 3.95
Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med (2001) 2.41
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation (1996) 2.09
Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology (1996) 2.07
Endoscopic ultrasound drainage of pancreatic pseudocyst: a prospective comparison with conventional endoscopic drainage. Endoscopy (2006) 1.90
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene (2001) 1.67
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer (1993) 1.66
Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. Am Surg (1999) 1.61
The evolution and direction of OPTN oversight of live organ donation and transplantation in the United States. Am J Transplant (2008) 1.61
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology (2000) 1.50
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA (1999) 1.49
The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann Surg (1991) 1.47
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity. Am J Transplant (2009) 1.44
Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41
Treatment of bilateral blunt carotid injury using percutaneous angioplasty and stenting: case report and review of the literature. J Trauma (2000) 1.40
Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg (2007) 1.39
Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches. Liver Transpl (2000) 1.39
A systems approach to surgical safety. Surg Endosc (2002) 1.34
Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J Natl Cancer Inst (1986) 1.31
Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg (1997) 1.31
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis (2009) 1.29
Outpatient laparoscopic cholecystectomy: patient outcomes after implementation of a clinical pathway. Ann Surg (2001) 1.28
Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol (2007) 1.11
Electrical counting and sizing of mammalian cells in suspension: an experimental evaluation. Phys Med Biol (1967) 1.10
Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes. Ann Surg (1986) 1.10
Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun (1985) 1.08
Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation (2001) 1.07
Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg (1999) 1.06
Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology (1998) 1.05
Fever patterns. Their lack of clinical significance. Arch Intern Med (1979) 1.04
Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg (2000) 1.04
Wound infections. Surg Clin North Am (1994) 1.04
Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Am J Kidney Dis (2000) 1.04
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02
A physical explantation of the bimodal distribution obtained by electronic sizing of erythrocytes. J Lab Clin Med (1969) 1.02
Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis. Endoscopy (2007) 1.02
Comparative studies on succinate and terminal oxidase activity in microbial and mammalian electron-transport systems. Can J Microbiol (1969) 1.01
Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant (2006) 1.00
Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. Am J Transplant (2007) 0.99
Gastropleural fistula. Report of three cases and review of the literature. Am J Surg (1985) 0.98
Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis. Arch Surg (1985) 0.98
Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened? Arch Surg (1999) 0.98
Identification of integrin-stimulated sites of serine phosphorylation in FRNK, the separately expressed C-terminal domain of focal adhesion kinase: a potential role for protein kinase A. Biochem J (1997) 0.96
Comparison of APACHE II scoring in liver and kidney transplant recipients versus trauma and general surgical patients in a single intensive-care unit. Clin Transplant (1995) 0.96
Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity. Liver Transpl (2000) 0.96
Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant (1995) 0.95
Proposed thresholds for pancreatic tissue volume for safe intraportal islet autotransplantation after total pancreatectomy. Am J Transplant (2013) 0.94
Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun (2001) 0.93
Accuracy and significance of pretransplant liver volume measured by magnetic resonance imaging. Liver Transpl Surg (1996) 0.93
Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant (1999) 0.92
Diagnosis of intra-abdominal infection in the critically ill patient. Curr Opin Crit Care (2001) 0.92
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol Cell Physiol (2013) 0.92
Percutaneous aspiration and drainage for suspected abdominal infection. Surgery (1984) 0.92
Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg (1992) 0.92
Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant (2000) 0.92
Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis. Infect Immun (2000) 0.92
Long-term survival in the elderly after trauma. J Trauma (2000) 0.91
Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg (1994) 0.91
Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am Surg (1992) 0.91
Cecal volvulus: a different twist for the serious runner. N Engl J Med (1985) 0.91
A simple method for bile duct anastomosis and interval bile collection in the liver-transplanted rat. J Surg Res (1992) 0.90
Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential. Am J Transplant (2013) 0.90
Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect (Larchmt) (2001) 0.90
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group. Transplantation (1996) 0.89
Recurrent trauma in elderly patients. Arch Surg (2001) 0.88
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg (1998) 0.88
Bacteremia associated with central venous catheter infection is not an independent predictor of outcomes. J Am Coll Surg (2000) 0.88
Surgical infection and the aging population. Am Surg (2001) 0.87
Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae. Infect Immun (1993) 0.87
Glucose metabolism after pancreas autotransplantation. The effect of open duct versus urinary bladder drainage technique. Ann Surg (1991) 0.87
Laparoscopic percutaneous jejunostomy for long term enteral access. Surg Endosc (1996) 0.87
Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation. Transplantation (1996) 0.86
Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis: VIII. A leukotoxin is produced by Escherichia coli metabolism in hemoglobin. Surgery (1984) 0.86
Recurrent variceal bleeding after liver transplantation--persistent left-sided portal hypertension. Transplantation (1992) 0.86
Impact of bloodstream infection on outcomes among infected surgical inpatients. Ann Surg (2001) 0.86
Cohort study of fever and leukocytosis as diagnostic and prognostic indicators in infected surgical patients. World J Surg (2001) 0.85
In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants. Infect Immun (1996) 0.84
Intern call schedules and their relationship to sleep, operating room participation, stress, and satisfaction. Surgery (1999) 0.84
Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery (1996) 0.83
Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism. Infect Immun (1998) 0.83
Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function. Transplantation (1998) 0.83
Communication gaps associated with donor-derived infections. Am J Transplant (2014) 0.83
Trauma-specific intensive care units can be cost effective and contribute to reduced hospital length of stay. Am Surg (2001) 0.82
The oversight of solid organ transplantation in the United States. Am J Transplant (2008) 0.82